Welcure Drugs & Pharmaceuticals Ltd. | Small-cap | Healthcare
₹12.96
4.94%
| Welcure Drugs Stock Comparison:
No comparison data available
Chart Range Statistics Financials Returns Ownership Calculator FAQ

Welcure Drugs Performance Comparison

Loading chart data...

Welcure Drugs
NIFTY 50
View Full Price History

Stock Range

Today's Range

Low: ₹12.95 High: ₹12.96
on July 9, 2025

52 Week Range

Low: ₹5.50 High: ₹15.89
on July 9, 2024
on June 23, 2025

All-Time High: ₹25.00 on September 19, 2005

Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights

Key Statistics

Market Cap i INR1.6B
EPS i N/A
P/E Ratio (TTM) i 39.86
Forward P/E i N/A
P/B Ratio i 1.08
PEG Ratio i N/A
Div. Yield i N/A
ROE i 4.18%
Beta i N/A
Debt to Equity i 120.18

Financial Highlights

Profitability

Gross Margin i 16.48%
Operating Margin i N/A
Profit Margin i N/A

Returns and Earnings

Return on Assets (TTM) i N/A
Return on Equity (TTM) i 4.18%
EBITDA i N/A
Net Income (TTM) i N/A

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i
Quarterly Revenue Growth i
Quarterly Earnings Growth i N/A

Peer Performance Comparison

No peer performance data available for this stock.

Ownership & Short Interest

Insider Ownership i 88.11%
Institutional Ownership i 0.00%
Shares Short i N/A
Short Ratio i N/A
Short % of Shares Outstanding i N/A
Average 10-Day Volume i 902K
Average 90-Day Volume i 351K

Welcure Drugs Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Welcure Drugs would have performed over time.

INR
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is WELCURE's 52-week high and low?

In the last 52 weeks, Welcure Drugs reached a high of ₹15.89 (on June 23, 2025) and a low of ₹5.50 (on July 9, 2024).

What is the market cap and P/E ratio for WELCURE?

Curious about Welcure Drugs's size and valuation? Its market capitalization stands at 1.61B. When it comes to valuation, the P/E ratio (trailing twelve months) is 39.86, and the forward P/E (looking ahead) is N/A.

Does WELCURE pay dividends? If so, what's the yield?

As for dividends, Welcure Drugs isn't currently offering a significant yield, or that specific data isn't available right now.

Who are Welcure Drugs's main competitors or similar companies to consider before investing?

When looking at Welcure Drugs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

No specific competitor data is currently available for comparison in this section.

What are the key financial health indicators for Welcure Drugs & Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)

To get a sense of Welcure Drugs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 4.18%, the Debt to Equity ratio from the most recent quarter is 120.18, and its Gross Profit Margin stands at 16.48%.

What is the recent revenue and earnings growth for WELCURE?

Looking at Welcure Drugs's growth, its revenue over the trailing twelve months (TTM) was INR246M. Compared to the same quarter last year (YoY), quarterly revenue grew by -200.00%, and quarterly earnings saw a YoY growth of N/A.

How much of WELCURE stock is held by insiders and institutions?

Wondering who owns Welcure Drugs stock? Company insiders (like executives and directors) hold about 88.11% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.